nalbuphine and Hypercapnia

nalbuphine has been researched along with Hypercapnia* in 2 studies

Trials

1 trial(s) available for nalbuphine and Hypercapnia

ArticleYear
Non-anesthesiologist-administered Propofol is not Related to an Increase in Transcutaneous CO
    Archivos de bronconeumologia, 2017, Volume: 53, Issue:9

    Evidence for the use of non-anesthesiologist-administered propofol for sedation during flexible bronchoscopy is scarce. The main objective of this study was to determine whether non-anesthesiologist-administered propofol balanced sedation was related to higher transcutaneous CO. In this randomized controlled trial we included data from outpatients aged 18 years or older with an indication for flexible bronchoscopy in a university hospital in northern Mexico.. Compared with guideline-recommended sedation, non-anesthesiologist-administered propofol balanced sedation is not associated with higher transcutaneous CO. NCT02820051.

    Topics: Adult; Aged; Ambulatory Care; Blood Gas Monitoring, Transcutaneous; Bronchoscopy; Carbon Dioxide; Deep Sedation; Female; Hospitals, University; Humans; Hypercapnia; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Nalbuphine; Nursing Assistants; Patient Satisfaction; Practice Guidelines as Topic; Propofol; Prospective Studies; Single-Blind Method

2017

Other Studies

1 other study(ies) available for nalbuphine and Hypercapnia

ArticleYear
Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1990, Volume: 37, Issue:2

    Reversal of opioid effects by naloxone (NX) can lead to significant cardiovascular problems. We have reported previously that hypercapnic dogs develop greater increases in blood pressure and plasma catecholamine (CA) levels than hypocapnic ones when reversed with naloxone. We have also demonstrated differences between NX and nalbuphine (NBPH) in producing excitatory adrenergic responses when administered during normocapnia. The present study was designed to investigate possible dissimilarities in cardiovascular and sympathetic events after administration of either NX or NBPH in dogs made hypercapnic following fentanyl administration. After induction of anaesthesia with thiopentone and intubation, two groups of dogs were maintained with controlled ventilation on enflurane in oxygen anaesthesia and given 50 micrograms.kg-1 fentanyl IV. This caused a significant decrease in heart rate (HR) (P less than 0.001), mean arterial blood pressure (MAP) (P less than 0.001), and plasma concentrations of norepinephrine (NE) (P less than 0.002). Then, ventilation was decreased to produce a PaCO2 of 60 mmHg; this was accompanied by a significant elevation in plasma level of both epinephrine (EPI) (P less than 0.02) and NE (P less than 0.001). Administration of 20 micrograms.kg-1 NX to six dogs resulted in immediate increases in HR (P less than 0.01) and MAP (P less than 0.01), and a further rise in CA levels to greater than pre-fentanyl baseline values. In six other dogs, NBPH (0.3 mg.kg-1) caused increases in HR (P less than 0.001) and MAP (P less than 0.001) only, and the MAP rise was significantly less than that seen in the NX group (P less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

    Topics: Analysis of Variance; Animals; Blood Pressure; Dogs; Epinephrine; Fentanyl; Heart Rate; Hypercapnia; Morphinans; Nalbuphine; Naloxone; Norepinephrine

1990